Enfuvirtide

Khoom npe: Enfuvirtide

Cas Tsis: 159519-65-0

Cov mis mos molecular: C204H301N51O64

Molecular Nyhav: 4491.945 g / mol

Ib theem zuj zus: Ac-Tyr-THR-Ser-Leu-Ile-Nws-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Nug-Gln-Gln-Glu-Lys-Nug-Glu-Gln-Glu-Leu- Leu-Glu-Leu-Asp-Lys-Trp-ALA-Ser-Leu-Trp-Nug-Trp-Phe-NH2 acetate ntsev

Tsos: Dawb hmoov

DAIM NTAWV THOV: Enfuvirtide yog ib tug tib neeg Immunodeficiency Tus kab mob no 1 Fusion inhibitor. Lub mechanism ntawm qhov kev txiav txim ntawm enfuvirtide yog raws li ib tug Fusion Protein inhibitor

POB: Raws li cov neeg uas yuav tsum tau

Xa email rau peb Download tau li PDF

khoom Nthuav dav

khoom cim npe

keywords

siab purity Enfuvirtide
feem ntau pheej yig tus nqi
CAS # 159519-65-0

ceev Paub meej

ProName: Enfuvirtide
CasNo: 159519-65-0
Molecular Formula: C204H301N51O64
Tsos: dawb hmoov
Daim ntawv: Tib neeg immunodeficiency virus hom 1 (H ...
DeliveryTime: pab zaub mov xa tuaj
Pob: raws li tus neeg muas zaub uas yuav tsum tau
Chaw nres nkoj: Shenzhen
ProductionCapacity: 2 kilogram / rau lub Hlis
Purity: 98%
Cia: 2 ~ 8 ℃
Tsheb thauj mus los: los ntawm huab cua
LimitNum: 1 gram

superiority

kev peptide chaw tsim tshuaj paus nyob rau hauv Tuam Tshoj.

zoo nrog GMP qib

loj scale nrog sis tw nqi

peb cov khoom muaj xws li: generic tej peptide APIs, kom hniav zoo nkauj peptide, kev cai peptides thiab kho tsiaj peptides.

molecular mis :

c204h301n51o64

txheeb ze molecular loj :

4491.945 g / mol

cas-tus naj npawb :

159519-65-0 (net)

long-term cia :

-20 ± 5 ° c

ib theem zuj zus :

ac -tyr-THR-ser-leu-ile-nws-ser-leu-ile-Glu-Glu-ser-gln-Nug-gln-gln-Glu-lys-Nug-Glu-gln-Glu-leu-leu- Glu-leu-nab taug-lys-trp-ala-ser-leu-trp-Nug-trp-phe-nh2 acetate ntsev

liaj teb ntawm daim ntawv thov :

human immunodeficiency virus hom 1 ( kab mob HIV -1) kab mob

enfuviritide yog siv nyob rau hauv ua ke nrog nrog rau lwm cov antiretroviral cov neeg ua hauj nyob rau hauv txoj kev kho-tej neeg mob uas muaj pov thawj ntawm kab mob HIV -1 replication txawm mus tsis tu ncua antiretroviral kho.

active tshuaj :

enfuvirtide yog ib tug 36 amino acid peptide coj mus rau ib cheeb tsam ntawm gp41, lub transmembrane subunit ntawm kab mob HIV-1 lub hnab ntawv protein.enfuvitide belongs rau lub tshuaj chav kawm ntawv ntawm fusion inhibitors thiab ua los ntawm losis tswvyim dabtsi rau gp41 thiab txwv cov conformational hloov nyob rau hauv gp41 tsim nyog rau fusion ntawm tus kab mob no nrog rau cov cell.

Paub meej

Tuam txhab Profile:

lub tuam txhab lub npe: Shenzhen JYMed Technology Co., Ltd.

Xyoo Tsim: 2009

Peev: 89,5 lab RMB

Main khoom: oxytocin acetate, Vasopressin acetate, Desmopressin acetate, Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin acetate, Glucagon acetate, Histrelin acetate, Liraglutide acetate, Linaclotide Aceteate, Degarelix acetate, Buserelin acetate, Cetrorelix acetate , Goserelin

Acetate, Argireline acetate, Metrixyl acetate, Snap-8, ... ..

Peb siv zog rau cov tseem nrhav nyob rau hauv tshiab peptide synthesis technology thiab cov txheej txheem optimization, thiab peb kev pab neeg muaj tshaj xyoo caum ntawm kev nyob rau hauv peptide synthesis.JYM tau ntse xa ntau

ntawm ANDA peptide APIs thiab formulated cov khoom uas muaj CFDA thiab muaj tshaj plaub caug patents pom zoo.

Peb peptide cog nyob rau hauv Nanjing, Jiangsu xeev thiab nws tau teem ib lub chaw ntawm 30,000 square meters nyob rau hauv kev ua raws cai nrog cGMP yeej. Cov kev siv thiab lub tsev raug audited thiab ntsuam xyuas los ntawm ob qho tib si domestic thiab thoob ntiaj teb neeg.

Nrog nws zoo heev zoo, feem ntau cov kev sib tw cov nqi thiab muaj zog kev them nyiaj yug, JYM tsis tsuas tau tau qhuas txog rau nws cov khoom los ntawm kev tshawb fawb cov koom haum thiab chaw ua tshuaj industries, tab sis kuj ua ib qho ntawm feem txhim khu kev qha lwm tus neeg uas peptides nyob rau hauv Tuam Tshoj ,. JYM yog nplooj siab mus yuav ib tug ntawm lub ntiaj teb no tus leading peptide mob nyob rau hauv lub nyob ze yav tom ntej.

Yav dhau los: Abaloparatide

Tom ntej: Eptifibatide

Enfuvirtide